Abstract:Deletion of SIRT1 in hepatocytes enhances NLRP3 signaling and triggers HSC activation and liver fibrosis in young mice in response to liver injury. Unlike young mice, age‐dependent defect of hepatic SIRT1 drives NLRP3 activation and inflammation, which amplifies the initial insult and creates a vicious circle that impairs the capability to resolve fibrosis in old mice even after injury cessation. NLRP3 inhibition by MCC950 ameliorates age‐ and alcohol‐induced liver fibrosis likely by reducing inflammatory cell infiltration and suppressing hepatocyte‐derived danger signaling. Our studies indicate that the longevity factor SIRT1 is implicated in metabolic disease; however, whether and how hepatocyte‐specific SIRT1 signaling is involved in liver fibrosis remains undefined. We characterized a functional link of age‐mediated defects in SIRT1 to the NLRP3 inflammasome during age‐related liver fibrosis. In multiple experimental murine models of liver fibrosis, we compared the development of liver fibrosis in young and old mice, as well as in liver‐specific SIRT1 knockout (SIRT1 LKO) mice and wild‐type (WT) mice. Liver injury, fibrosis, and inflammation were assessed histologically and quantified by real‐time PCR analysis. In a model of hepatotoxin‐induced liver fibrosis, old mice displayed more severe and persistent liver fibrosis than young mice during liver injury and after injury cessation, as characterized by inhibition of SIRT1, induction of NLRP3, infiltration of macrophages and neutrophils, activation of hepatic stellate cells (HSCs), and excessive deposition and remodeling of the extracellular matrix. Mechanistically, deletion of SIRT1 in hepatocytes resulted in NLRP3 and IL‐1β induction, pro‐inflammatory response, and severe liver fibrosis in young mice, mimicking the ability of aging to impair the resolution of established fibrosis. In an aging mouse model, chronic‐plus‐binge alcohol feeding‐induced liver fibrosis was attenuated by treatment with MCC950, a selective NLRP3 inhibitor. NLRP3 inhibition ameliorated alcoholic liver fibrosis in old mice by repressing inflammation and reducing hepatocyte‐derived danger signaling—ASK1 and HMGB1. In conclusion, age‐dependent SIRT1 defects lead to NLRP3 activation and inflammation, which in turn impairs the capacity to resolve fibrosis during aging.

Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice

Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development

SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice

Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress.

Hepatic SIRT6 Deficit Promotes Liver Tumorigenesis in the Mice Models

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate CellsSummary

Impaired reciprocal regulation between SIRT6 and TGF- signaling in fatty liver

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells

Hepatic-Specific Disruption of Sirt6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis

Impaired reciprocal regulation between SIRT6 and TGF‐β signaling in fatty liver

Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium

Hepatic Sirt6 activation abrogates acute liver failure

SIRT6 Inhibits Inflammatory Response Through Regulation of NRF2 in Vascular Endothelial Cells

Sirtuin 6 is a Negative Regulator of the Anti-Tumor Function of Natural Killer Cells in Murine Inflammatory Colorectal Cancer

SIRT6 Protects Against Liver Fibrosis by Negatively Regulating YAP/TAZ

Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells

Sirtuin 6 Protects Against Hepatic Fibrogenesis by Suppressing the YAP and TAZ Function.

SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells

Protective Effects of SIRT6 Overexpression against DSS-Induced Colitis in Mice

Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution